Literature DB >> 23371443

No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a Tunisian population.

Afef Achouri Rassas1, Sondess Hadj Fredj, Hela Mrabet Khiari, Safa Sahnoun, Amina Bibi, Hajer Siala, Amel Mrabet, Taieb Messaoud.   

Abstract

We examined the potential involvement of the polymorphism in intron 8 of the presenilin-1 (PSEN1) gene as a risk factor for Alzheimer disease (AD), both through independent effect and interaction with the apolipoprotein E (APOE) ε4 allele risk, in 85 patients and 90 controls. We found no significant differences in the distribution of PSEN1 genotype and allele frequency between both groups; and post stratification distribution with APOE ε4 allele. Age of onset suggests that this polymorphism influences AD progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371443     DOI: 10.1007/s00702-013-0985-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  22 in total

1.  PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.

Authors:  Olivia Belbin; Helen Beaumont; Donald Warden; A David Smith; Noor Kalsheker; Kevin Morgan
Journal:  Neurobiol Aging       Date:  2008-04-09       Impact factor: 4.673

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Association between presenilin 1 intronic polymorphism and late onset Alzheimer's disease in the North Chinese population.

Authors:  Longfei Jia; Chunkui Zhou; Haiyan Lv; Weishan Wang; Jing Ye; Xiaojun Zhang; Weidong Zhou; Jiangtao Xu; Lingling Wang; Jianping Jia
Journal:  Brain Res       Date:  2006-08-30       Impact factor: 3.252

4.  No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population.

Authors:  M Bagli; A Papassotiropoulos; S G Schwab; F Jessen; M L Rao; W Maier; R Heun
Journal:  J Neurol Sci       Date:  1999-08-01       Impact factor: 3.181

5.  Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease.

Authors:  N Sodeyama; Y Itoh; N Suematsu; M Matsushita; E Otomo; H Mizusawa; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

6.  High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population.

Authors:  Afef Achouri Rassas; Hela Mrabet Khiari; Sondes Hadj Fredj; Safa Sahnoun; Hend Batti; Nouria Oudiaa Zakraoui; Aroua Cherif; Nadia Anane; Nadia Ben Ali; Taieb Messaoud; Amel Mrabet
Journal:  Neurol Sci       Date:  2011-06-28       Impact factor: 3.307

7.  Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease.

Authors:  M Yasuda; N Hirono; K Maeda; T Imamura; E Mori; C Tanaka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

8.  No association between presenilin 1 (PS1) intronic polymorphism and sporadic Alzheimer's disease in Koreans.

Authors:  K W Kim; J H Jhoo; K U Lee; D Y Lee; J H Lee; J Y Youn; B J Lee; J I Woo
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

9.  Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group.

Authors:  M Wragg; M Hutton; C Talbot
Journal:  Lancet       Date:  1996-02-24       Impact factor: 79.321

10.  Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

Authors:  P Kehoe; J Williams; S Lovestone; G Wilcock; M J Owen
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

View more
  1 in total

1.  Combined association of Presenilin-1 and Apolipoprotein E polymorphisms with maternal meiosis II error in Down syndrome births.

Authors:  Pranami Bhaumik; Priyanka Ghosh; Sujay Ghosh; Eleanor Feingold; Umut Ozbek; Biswanath Sarkar; Subrata Kumar Dey
Journal:  Genet Mol Biol       Date:  2017-07-31       Impact factor: 1.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.